POMC and Anxiety: Notably, the significant genotype–treatment effect for the light zone time, with the GFAP KI–ACTH treatment showing a significant effect compared with all other groups, suggests that the effect of treatment on reducing anxiety was more pronounced in the GFAP KI genotype group.